Alina Meyer

Doktorand vid Institutionen för farmaci; Läkemedelsformulering

E-post:
alina.meyer@farmaci.uu.se
Besöksadress:
Biomedicinskt Centrum BMC, Husargatan 3
752 37 Uppsala
Postadress:
Box 580
751 23 UPPSALA

Nyckelord

  • adme
  • adpkd
  • drug discovery
  • drug repurposing
  • drugtrain
  • kidney disease
  • organoids
  • pkpd

Forskning

Denna text finns inte på svenska, därför visas den engelska versionen.

The general aim of my PhD thesis is to pharmaceutically profile new repurposing candidates for the treatment of the hereditary kidney disease ADPKD. I will perform a series of ADME assays. Then, the intracellular compound concentration and the corresponding pharmacological effect will be investigated using 3D cultured kidney organoids and global proteomics. Furthermore, subcellular target and off-target interaction for lead candidates will be studied and the findings will be combined in a PBPK model.

The project is part of the EU 'DRUGtrain' network.

Alina Meyer

FÖLJ UPPSALA UNIVERSITET PÅ

facebook
instagram
twitter
youtube
linkedin